Emerging sources and applications of alternative proteins /

Protein nutrition and sustainability is a global challenge.Emerging Sources and Applications of Food Proteins provides the latest progresses about research and applications of emerging alternative proteins.

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Other Authors: Wu, Jianping (Professor) (Editor)
Format: eBook
Language:English
Published: Amsterdam : Academic Press, 2022.
Series:Advances in food and nutrition research ; v. 101.
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Intro
  • Emerging Sources and Applications of Alternative Proteins
  • Copyright
  • Contents
  • Contributors
  • Preface
  • Chapter One: Emerging sources and applications of alternative proteins: An introduction
  • 1. Why do we need alternative proteins?
  • 2. What are the alternative proteins?
  • 3. What are the applications of alternative proteins?
  • 4. Conclusions
  • References
  • Chapter Two: Extraction, nutrition, functionality and commercial applications of canola proteins as an underutilized plan ...
  • 1. Introduction
  • 2. Canola protein characterization
  • 2.1. Napin and cruciferin
  • 2.1.1. Structural characteristics
  • 2.1.2. Isoelectric point (pI)
  • 2.1.3. Molecular weight
  • 2.1.4. Structural stability against heating, pH alteration, and reducing agents
  • 2.2. Other proteins
  • 3. Canola protein extraction
  • 3.1. Canola protein concentrate
  • 3.2. Canola protein isolate
  • 3.2.1. Alkaline extraction
  • 3.2.1.1. Solubilization stage
  • 3.2.1.2. Precipitation stage
  • 3.2.1.3. Simultaneous production of napin-rich and cruciferin-rich isolates
  • 3.2.2. Salt extraction
  • 4. Extraction-assisting technologies
  • 5. Protein quality: Nutritional value and digestibility, and bioactivity
  • 5.1. Nutritional aspects and digestibility
  • 5.2. Canola proteins bioactivity
  • 5.2.1. ACE-inhibitory activity
  • 5.2.2. Antioxidant activity
  • 6. Functional properties
  • 6.1. Solubility
  • 6.1.1. Solubility of canola protein concentrates
  • 6.1.2. Solubility of canola protein isolates
  • 6.1.3. Solubility comparison to other protein sources
  • 6.2. Emulsifying
  • 6.2.1. Emulsifying of canola protein concentrates
  • 6.2.2. Emulsifying of canola protein isolates
  • 6.2.3. Comparison to other protein sources
  • 6.3. Foaming
  • 6.3.1. Foaming of canola protein isolates
  • 6.3.2. Comparison to other plant proteins
  • 6.4. Gelation.
  • 6.4.1. Gelation of canola protein concentrates
  • 6.4.2. Gelation of canola protein isolates
  • 6.4.3. Comparison to other plant proteins
  • 7. Commercial canola protein products
  • 8. Conclusion
  • References
  • Chapter Three: Pea protein composition, functionality, modification, and food applications: A review
  • 1. Introduction
  • 2. Pea protein
  • 3. Functional properties
  • 3.1. Water holding capacity
  • 3.2. Oil holding capacity
  • 3.3. Solubility
  • 3.4. Emulsifying properties
  • 3.5. Foaming properties
  • 3.6. Gelation
  • 4. Protein modifications
  • 4.1. Enzymatic modification
  • 4.2. Protein-polysaccharide conjugation/complexation
  • 4.3. Acylation
  • 4.4. Deamidation
  • 4.5. Physical modification
  • 5. Applications
  • 5.1. Meat analogs and meat extenders
  • 5.2. Bakery applications
  • 5.3. Dressings
  • 5.4. Beverages
  • 5.5. Dairy products and analogs
  • 5.6. Encapsulating wall materials
  • 5.7. Pickering particles
  • 6. Conclusions
  • Acknowledgments
  • References
  • Chapter Four: Edible insects, a valuable protein source from ancient to modern times
  • 1. Humand entomophagy: Historical, nutritional and sustainability perspective
  • 2. Traditional methods and commercial processing technologies used for insects
  • 3. Applications of insect protein in food and beverage formulations
  • 4. Challenges and future prospects of insect protein
  • 5. Conclusion
  • References
  • Further reading
  • Chapter Five: Fungal protein
  • 1. Introduction
  • 2. Fungi
  • 3. Production process
  • 4. Regulatory oversight
  • 5. The fungal protein market
  • 6. Public acceptance
  • 7. Nutritional aspects
  • 8. Health impact
  • 9. Safety concerns
  • 10. Ethics
  • 11. Social aspects
  • 12. Environmental aspects
  • 13. Future trends
  • References
  • Chapter Six: Should and will ``cultured meat´´ become a reality in our plates?.
  • 1. Introduction: Meat production issues and the context of ``cultured meat´´ development
  • 2. Where do we stand with its development and marketing?
  • 2.1. What is it? How is it made?
  • 2.2. Who produces it? Who markets it? Who has plans to do so in the short-term?
  • 2.3. What role does research play?
  • 3. What are the challenges of commercial ``cultured meat´´ production?
  • 3.1. Mass production at low cost
  • 3.2. Environmental assessment
  • 3.3. Quality of this new product
  • 3.4. Cost of ``cultured meat´´ and start-ups in the sector
  • 3.5. Can we do without animals to produce ``cultured meat´´?
  • 3.5.1. The need to slaughter animals
  • 3.5.2. The need for foetal bovine serum
  • 3.5.3. The future of animals if we do not need them
  • 3.6. Is ``cultured meat´´ really meat? What are the legal issues?
  • 3.7. What is the religious status of ``cultured meat´´?
  • 4. What do consumers think?
  • 4.1. Methodology of the surveys
  • 4.2. Main results
  • 5. Conclusion and outlook
  • References
  • Chapter Seven: Meat alternatives: A proofed commodity?
  • 1. Introduction
  • 2. Main non-animal alternative protein sources used in meat alternatives
  • 2.1. Soybeans
  • 2.2. Gluten
  • 2.3. Peas
  • 2.4. Fungi
  • 2.5. Algae
  • 2.6. Edible insects
  • 3. Plant-based meat alternatives
  • 4. Fungi-based meat alternatives
  • 5. Algae-based meat alternatives
  • 6. Insect-based meat alternatives
  • 7. Cell-based meat
  • 8. Conclusion
  • References
  • Chapter Eight: Fabrication of protein nanomaterials as delivery systems
  • 1. Introduction
  • 2. Fabrication of protein nanocarriers
  • 2.1. Protein nanoparticles
  • 2.1.1. Desolvation
  • 2.1.2. Non-solvent nanoprecipitation
  • 2.1.3. Salting out
  • 2.1.4. Nanoparticle albumin-bound (nab) technology
  • 2.1.5. Self-assembly
  • 2.1.6. Complex coacervation method
  • 2.1.7. Emulsion/solvent extraction.
  • 2.1.8. Electrospray technique
  • 2.2. Protein nanoemulsion
  • 2.2.1. High-energy approaches
  • 2.2.1.1. High-pressure valve homogenization
  • 2.2.1.2. Microfluidization
  • 2.2.1.3. Ultrasonication
  • 2.2.2. Low-energy approaches
  • 2.2.2.1. Membrane emulsification
  • 2.2.2.2. Spontaneous emulsification
  • 2.2.2.3. Emulsion phase inversion
  • 3. Conclusions and future perspectives
  • References
  • Chapter Nine: Food protein-derived bioactive peptides for the management of nutrition related chronic diseases
  • 1. Introduction
  • 2. An overview of nutrition related chronic diseases
  • 2.1. The prevalence of nutrition related chronic diseases
  • 2.2. The pathophysiology of nutrition related chronic diseases
  • 2.2.1. The pathophysiology of hypertension
  • 2.2.2. The pathophysiology of T2DM
  • 2.2.3. The pathophysiology of dyslipidemia
  • 2.3. Management of nutrition related chronic diseases by lifestyle modifications
  • 2.3.1. Physical activity and nutrition related chronic diseases
  • 2.3.2. Dietary intervention of nutrition related chronic diseases
  • 3. The potential of food protein-derived bioactive peptides in improving human health
  • 3.1. An overview of food protein-derived bioactive peptides
  • 3.2. The production of bioactive peptides
  • 3.2.1. Hydrolysis
  • 3.2.2. Fermentation
  • 3.3. Bioactivities of food protein-derived peptides
  • 3.3.1. Antioxidant peptides
  • 3.3.2. Antihypertensive peptides
  • 3.3.3. Antidiabetic peptides
  • 3.3.4. Anti-obesity peptides
  • 3.3.5. Hypolipidemic peptides
  • 3.3.6. Peptides with other bioactivities
  • 3.4. Bioavailability of bioactive peptides
  • 3.5. Safety considerations of bioactive peptides
  • 4. Clinical evidence of bioactive peptides in management of nutrition related chronic diseases
  • 4.1. Clinical trials of antihypertensive peptides
  • 4.2. Clinical trials of peptides in ameliorating T2DM.
  • 4.2.1. Chronic studies
  • 4.2.2. Acute studies
  • 4.3. Clinical trials of peptides modulating blood lipid profile
  • 5. Prospective trends
  • References.